0001209191-21-009464.txt : 20210210
0001209191-21-009464.hdr.sgml : 20210210
20210210201140
ACCESSION NUMBER: 0001209191-21-009464
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: APPLE ROBERT F
CENTRAL INDEX KEY: 0001054942
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 21616017
MAIL ADDRESS:
STREET 1: C/O INKLINE PHARMACEUTICAL CO INC
STREET 2: SENTRY PARK EAST 1720 WALTON ROAD
CITY: BLUE BELL
STATE: PA
ZIP: 19422
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-08
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001054942
APPLE ROBERT F
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
1
0
0
President & CEO
Common Stock
2021-02-08
4
M
0
33574
2.62
A
2328729
D
Common Stock
2021-02-08
4
S
0
33574
4.75
D
2295155
D
Common Stock
2021-02-09
4
M
0
49129
2.62
A
2344284
D
Common Stock
2021-02-09
4
S
0
49129
4.75
D
2295155
D
Common Stock
2021-02-10
4
M
0
7278
2.62
A
2302433
D
Common Stock
2021-02-10
4
S
0
7278
4.75
D
2295155
D
Stock Option (right to buy)
2.62
2021-02-08
4
M
0
33574
0.00
D
2025-03-09
Common Stock
33574
0
D
Stock Option (right to buy)
2.62
2021-02-09
4
M
0
49129
0.00
D
2025-03-09
Common Stock
49129
0
D
Stock Option (right to buy)
2.62
2021-02-10
4
M
0
7278
0.00
D
2025-03-09
Common Stock
12797
0
D
The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The options vested in equal quarterly installments over one year from the grant date of March 10, 2015.
/s/Keith Muckenhirn as attorney-in-fact for Robert F. Apple
2021-02-10